Get started
Author

Kazuaki Ikejiri

Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption
2012 · Yoshihisa Shitara, Kazuya Maeda, et al. · Biopharmaceutics & Drug Disposition · 425
Comparison of Methods for Estimating Unbound Intracellular-to-Medium Concentration Ratios in Rat and Human Hepatocytes Using Statins
2017 · Takashi Yoshikado, Kota Toshimoto, et al. · Drug Metabolism and Disposition · 54
PDF
Effect of Coadministration of Single and Multiple Doses of Rifampicin on the Pharmacokinetics of Fexofenadine Enantiomers in Healthy Subjects
2012 · Hiroyuki Kusuhara, Masatomo Miura, et al. · Drug Metabolism and Disposition · 45
Evocalcet: A New Oral Calcimimetic for Dialysis Patients With Secondary Hyperparathyroidism
2019 · Tadao Akizawa, Kazuaki Ikejiri, et al. · Therapeutic Apheresis and Dialysis · 43
PDF
Dose-Response of Tenapanor in Patients With Hyperphosphatemia Undergoing Hemodialysis in Japan—A Phase 2 Randomized Trial
2021 · Masaaki Inaba, Yotaro Une, et al. · Kidney International Reports · 28
PDF
Therapeutic Effects of Add-On Tenapanor for Hemodialysis Patients with Refractory Hyperphosphatemia
2021 · Takashi Shigematsu, Yotaro Une, et al. · American Journal of Nephrology · 23
Randomized Study of Tenapanor Added to Phosphate Binders for Patients With Refractory Hyperphosphatemia
2023 · Kosaku Nitta, Saki Itoyama, et al. · Kidney International Reports · 21
PDF
Tenapanor for the Treatment of Hyperphosphatemia in Japanese Hemodialysis Patients: A Randomized Phase 3 Monotherapy Study With an Up-titration Regimen
2023 · Masafumi Fukagawa, Natsuki Urano, et al. · American Journal of Kidney Diseases · 20
PDF
Effect of Tenapanor on Phosphate Binder Pill Burden in Hemodialysis Patients
2021 · Tadao Akizawa, Yu Sato, et al. · Kidney International Reports · 20
Radiosynthesis of novel pitavastatin derivative ([18F]PTV‐F1) as a tracer for hepatic OATP using a one‐pot synthetic procedure
2016 · Hiroyuki Kimura, Yusuke Yagi, et al. · Journal of Labelled Compounds and Radiopharmaceuticals · 8
Tenapanor: A novel therapeutic agent for dialysis patients with hyperphosphatemia
2025 · Tadao Akizawa, Natsuki Urano, et al. · Therapeutic Apheresis and Dialysis · 7
PDF
Effects of NRF2 polymorphisms on safety and efficacy of bardoxolone methyl: subanalysis of TSUBAKI study
2023 · Kazuaki Ikejiri, Takafumi Suzuki, et al. · Clinical and Experimental Nephrology · 5
PDF
Efficacy and Safety of Tenapanor in Japanese Peritoneal Dialysis Patients with Hyperphosphatemia: Results of a Phase 3 Study
2023 · Minoru Kubota, Kazuaki Ikejiri, et al. · Journal of the American Society of Nephrology
Efficacy and Safety of Tenapanor on Hyperphosphatemia in Japanese Hemodialysis Patients: Results of a Randomized Phase 3 Trial
2022 · Masafumi Fukagawa, Kazuaki Ikejiri, et al. · Journal of the American Society of Nephrology
In Reply to “Letter Regarding ‘Dose-Response of Tenapanor in Patients With Hyperphosphatemia Undergoing Hemodialysis in Japan—A Phase 2 Randomized Trial’”
2022 · Masaaki Inaba, Yotaro Une, et al. · Kidney International Reports
Works count: 15
Citation count: 699
H-index: 9
I10-index: 9
Year
Topic
Type